Organization Overview
Alternative names
acetylcysteine (mucomyst) (1 trial)
atorvastatin (lipitor) (1 trial)
bisacodyl (Halflytely) (2 trials)
Bismuth Subcitrate Potassium (Pylera) (4 trials)
bortezomib (velcade) (3 trials)
calcitriol (rocaltrol) (1 trial)
carboplatin (paraplatin) (13 trials)
cisplatin (platinol) (17 trials)
clarithromycin (biaxin) (12 trials)
clostridium butyricum (2 trials)
cyclophosphamide (cytoxan) (11 trials)
dexmedetomidine (precedex) (1 trial)
docetaxel (taxotere) (15 trials)
eltrombopag (promacta) (4 trials)
enoxaparin (lovenox) (1 trial)
esomeprazole (nexium) (7 trials)
etoposide (vepesid) (9 trials)
Filgrastim (neupogen) (4 trials)
fluorouracil (efudex) (4 trials)
furazolidone (furoxone) (12 trials)
glycyrrhetinic acid hydrogen succinate (1 trial)
heparin (liquaemin) (2 trials)
hydroxychloroquine (plaquenil) (2 trials)
ilaprazole (noltec) (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
levofloxacin (levaquin) (9 trials)
lidocaine (xylocaine) (3 trials)
mercaptopurine (purinethol) (3 trials)
metronidazole (flagyl) (10 trials)
nitroglycerin (transderm-nitro) (1 trial)
omeprazole (prilosec) (1 trial)
oseltamivir (tamiflu) (2 trials)
pantoprazole (protonix) (2 trials)
pegaspargase (oncaspar) (3 trials)
pemetrexed (alimta) (7 trials)
pirfenidone (esbriet) (2 trials)
polyethylene glycol (9 trials)
prednisolone (hydeltra) (1 trial)
prednisone (meticorten) (6 trials)
procaine benzylpenicillin (novocaine) (3 trials)
rabeprazole (pariet) (2 trials)
ribavirin (virazole) (1 trial)
rituximab (rituxan) (9 trials)
ruxolitinib (jakafi) (2 trials)
sargramostim (leukine) (5 trials)
somatropin (protropin) (3 trials)
tacrolimus (prograf) (3 trials)
tetracycline (tetrex) (13 trials)
tinidazole (tindamax) (9 trials)
tofacitinib (xeljanz) (1 trial)
vancomycin (Vancocin) (1 trial)
vonoprazan (Voquezna) (4 trials)
131i-lipiodol (Lipiodol) (1 trial)
bevacizumab (avastin) (6 trials)
bivalirudin (angiomax) (1 trial)
bleomycin (blenoxane) (2 trials)
capecitabine (xeloda) (6 trials)
cladribine (leustatin) (1 trial)
cyclosporine (sandimmune) (2 trials)
cytarabine (cytosar-u) (7 trials)
dactinomycin (cosmegen) (3 trials)
doxorubicin (Doxil) (4 trials)
follitropin alfa (Gonal-F) (1 trial)
fosfomycin (monurol) (1 trial)
gemcitabine (gemzar) (6 trials)
immune globulin (human) (Gamastan) (1 trial)
metoprolol (lopressor) (2 trials)
osimertinib (tagrisso) (1 trial)
paclitaxel (taxol) (19 trials)
allogeneic cord blood (1 trial)
allogeneic mesenchymal stem cells (1 trial)
allogeneic natural killer cells (2 trials)
aminolevulinic acid (levulan) (2 trials)
autologous adipose-derived mesenchymal stem cells (2 trials)
autologous tumor infiltrating lymphocytes (1 trial)
azacitidine (vidaza) (2 trials)
Adenocarcinoma (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Aneurysm (Phase 3)
Angina Pectoris (Phase 4)
Angina, Stable (Phase 4)
Anovulation (Phase 3)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Atherosclerosis (Phase 2)
Brain Neoplasms (Phase 2)
Breast Diseases (Phase 3)
Breast Neoplasms (Phase 4)
Bronchiectasis (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma in Situ (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 4)
Carcinoma, Squamous Cell (Phase 3)
Central Nervous System Neoplasms (Phase 2)
Cerebral Infarction (Phase 4)
Cervical Intraepithelial Neoplasia (Phase 2)
Cognitive Dysfunction (Phase 2)
Communicable Diseases (Phase 4)
Constipation (Phase 3)
Coronavirus Infections (Phase 3)
Delirium (Phase 4)
Dermatitis (Phase 2)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Disease Susceptibility (Phase 4)
Dwarfism, Pituitary (Phase 4)
Endocarditis (Phase 4)
Endocrine System Diseases (Phase 4)
Endometrial Neoplasms (Phase 3)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 3)
Esophagitis (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Fibrosis (Phase 4)
Gallbladder Neoplasms (Phase 3)
Gestational Trophoblastic Disease (Phase 3)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Heart Failure (Phase 4)
Heart Failure, Systolic (Phase 3)
Helicobacter Infections (Phase 4)
Hematologic Neoplasms (Phase 4)
Hemophilia A (Phase 3)
Hemorrhage (Phase 3)
Herpangina (Phase 4)
Hypertension (Phase 3)
Hypertension, Portal (Phase 4)
IgA Vasculitis (Phase 4)
Infarction (Phase 2)
Infections (Phase 4)
Influenza, Human (Phase 4)
Intracranial Aneurysm (Phase 3)
Irritable Bowel Syndrome (Phase 4)
Ischemia (Phase 4)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Liver Cirrhosis (Phase 4)
Lung Neoplasms (Phase 4)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, T-Cell (Phase 2)
Malnutrition (Phase 1)
Metaplasia (Phase 4)
Microvascular Angina (Phase 4)
Mucositis (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 4)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Second Primary (Phase 2)
Nephritis (Phase 4)
Nephrosis (Phase 4)
Nephrotic Syndrome (Phase 4)
Nervous System Neoplasms (Phase 2)
Neutropenia (Phase 2)
Non-ST Elevated Myocardial Infarction (Phase 4)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Osteosarcoma (Phase 4)
Ovarian Neoplasms (Phase 4)
Pancreatic Neoplasms (Phase 1)
Papillomavirus Infections (Phase 2)
Plaque, Atherosclerotic (Phase 2)
Pneumonia (Phase 3)
Preleukemia (Phase 2)
Prostatic Neoplasms (Phase 1)
Prosthesis Failure (Phase 3)
Purpura (Phase 4)
Purpura, Thrombocytopenic (Phase 4)
Purpura, Thrombocytopenic, Idiopathic (Phase 4)
Radiodermatitis (Phase 2)
Severe Acute Respiratory Syndrome (Phase 3)
Sex Cord-Gonadal Stromal Tumors (Phase 3)
Small Cell Lung Carcinoma (Phase 2)
Spondylitis (Phase 1)
Spondylitis, Ankylosing (Phase 1)
Stomach Neoplasms (Phase 4)
Stroke (Phase 4)
Subarachnoid Hemorrhage (Phase 3)
Syndrome (Phase 4)
Thrombocytopenia (Phase 4)
Thrombosis (Phase 4)
Triple Negative Breast Neoplasms (Phase 4)
Trophoblastic Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Venous Thrombosis (Phase 4)